This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Couto, M A Articles by Lehrer, R I Search for Related Content PubMed PubMed Citation Articles by Couto, M A Articles by Lehrer, R I

 Previous Article  |  Next Article 

Infect Immun. 1992 December; 60(12): 5042-5047

eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes.

Department of Reproduction, School of Veterinary Medicine, University of California, Davis 95616.

ABSTRACT

We purified a novel cysteine-rich antibiotic peptide, eNAP-2 (M(r), approximately 6,500), from acid extracts of equine neutrophils by sequential gel filtration and reversed-phase high-performance liquid chromatography and determined its partial N-terminal amino acid sequence. Although its cysteine motif distinguished eNAP-2 from all other currently known endogenous antibiotic peptides, including defensins and granulins, it showed substantial sequence similarity to WDNM1, a putative member of the four-disulfide-core protein family that also includes animal and human antiproteases, snake venom neurotoxins, and rat and mouse whey proteins. The antibacterial properties of eNAP-2 were tested against several equine uterine pathogens, namely, Streptococcus zooepidemicus, Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Killing of S. zooepidemicus was very efficient, as evidenced by a 94% decrease in numbers of CFU per milliliter after exposure to 100 micrograms of eNAP-2 per ml (approximately 15 microM) for 2 h. Exposure of E. coli and P. aeruginosa to 200 micrograms of eNAP-2 per ml for 2 h resulted in 90.2 and 77.6% reduction, respectively, in the numbers of CFU per milliliter. Bacteriostasis, without bactericidal activity, occurred after K. pneumoniae was incubated with 200 micrograms of eNAP-2 per ml. Additional studies will be required in other species and cell types to determine whether eNAP-2 is restricted to equine neutrophils or is the index member of a larger family of endogenous antibiotics.

This article has been cited by other articles:

• Bellemare, A., Vernoux, N., Morisset, D., Bourbonnais, Y. (2008). Human Pre-Elafin Inhibits a Pseudomonas aeruginosa-Secreted Peptidase and Prevents Its Proliferation in Complex Media. Antimicrob. Agents Chemother. 52: 483-490 [Abstract] [Full Text]  
• Hanington, P. C., Barreda, D. R., Belosevic, M. (2006). A Novel Hematopoietic Granulin Induces Proliferation of Goldfish (Carassius auratus L.) Macrophages. J. Biol. Chem. 281: 9963-9970 [Abstract] [Full Text]  
• Fernie-King, B. A., Seilly, D. J., Davies, A., Lachmann, P. J. (2002). Streptococcal Inhibitor of Complement Inhibits Two Additional Components of the Mucosal Innate Immune System: Secretory Leukocyte Proteinase Inhibitor and Lysozyme. Infect. Immun. 70: 4908-4916 [Abstract] [Full Text]  
• Skerlavaj, B., Scocchi, M., Gennaro, R., Risso, A., Zanetti, M. (2001). Structural and Functional Analysis of Horse Cathelicidin Peptides. Antimicrob. Agents Chemother. 45: 715-722 [Abstract] [Full Text]  
• Risso, A. (2000). Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J. Leukoc. Biol. 68: 785-792 [Abstract] [Full Text]  
• Kuroki, J., Hosoya, T., Itakura, M., Hirose, S., Tamechika, I., Yoshimoto, T., Ghoneim, M. A., Nara, K., Kato, A., Suzuki, Y., Furukawa, M., Tachibana, S. (1995). Cloning, Characterization, and Tissue Distribution of Porcine SPAI, a Protein with a Transglutaminase Substrate Domain and the WAP Motif. J. Biol. Chem. 270: 22428-22433 [Abstract] [Full Text]